|
US2020397945A1
|
|
Biological Formulations and Methods for Treating Cardiac Tissue and Disorders
|
|
US2020368393A1
|
|
Biological Formulations and Methods for Treating Cardiac Tissue and Disorders
|
|
US2020022808A1
|
|
Prosthetic cardiovascular valves and methods for replacing native atrioventricular valves with same
|
|
US2020069840A1
|
|
Prosthetic Tissue Valves
|
|
US2019314551A1
|
|
Extracellular Matrix Tissue Prostheses
|
|
US2019134266A1
|
|
Prosthetic tissue valves and methods for replacing native atrioventricular valves with same
|
|
US2019083257A1
|
|
Prosthetic tissue valves and methods for replacing native atrioventricular valves with same
|
|
US2019008634A1
|
|
Prosthetic tissue valves
|
|
US2018147241A1
|
|
Compositions and methods for treatment of cardiovascular disorders
|
|
US2018153686A1
|
|
Prosthetic Tissue Valves
|
|
US2018104050A1
|
|
Systems, Apparatus and Methods for Sealing Perivalvular Leaks
|
|
CA3010717A1
|
|
Prosthetic tissue valves
|
|
EP3380044A1
|
|
Prosthetic tissue valves
|
|
US2017100522A1
|
|
Cardiovascular prostheses
|
|
US2017100516A1
|
|
Cardiovascular Prostheses
|
|
US2017100517A1
|
|
Cardiovascular Prostheses
|
|
US2017100512A1
|
|
Cardiovascular Prostheses
|
|
US2017100514A1
|
|
Cardiovascular Prostheses
|
|
US2017100518A1
|
|
Cardiovascular prostheses
|
|
US2017100513A1
|
|
Cardiovascular Prostheses
|
